Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析

◆英語タイトル:Syndax Pharmaceuticals Inc (SNDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH137805FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Syndax Pharmaceuticals Inc (Syndax) is a biopharmaceutical company that develops and commercializes therapies for multiple cancer indications. The company’s lead product candidate includes entinostat, an oral, small molecule drug candidate, which is in phase 3 clinical trial used for the treatment of advanced hormone receptor positive and human epidermal growth factor receptor 2 negative breast cancer. Its product candidate is also used for the treatment of non-small cell lung cancer and melanoma, ovarian cancer and other indications. Syndax also develops SNDX-6352, a monoclonal antibody that targets the CSF-1 receptor. The company operates through its offices in Waltham and New York City, the US. Syndax is headquartered in Waltham, Massachusetts, the US.

Syndax Pharmaceuticals Inc Key Recent Developments

Mar 08,2021: Syndax Pharmaceuticals reports fourth quarter 2020 financial results and provides clinical and business update
Mar 08,2021: Syndax Pharmaceuticals announces reports Q4 results
Dec 18,2020: Syndax Pharmaceuticals to be added to the NASDAQ Biotechnology Index
Nov 02,2020: Syndax Pharmaceuticals reports third quarter 2020 financial results and provides clinical and business update
Aug 06,2020: Syndax Pharmaceuticals reports second quarter 2020 financial results and provides clinical and business update

This comprehensive SWOT profile of Syndax Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Syndax Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Syndax Pharmaceuticals Inc – Key Information
Syndax Pharmaceuticals Inc – Overview
Syndax Pharmaceuticals Inc – Key Employees
Syndax Pharmaceuticals Inc – Key Employee Biographies
Syndax Pharmaceuticals Inc – Key Operational Heads
Syndax Pharmaceuticals Inc – Major Products and Services
Syndax Pharmaceuticals Inc – History
Syndax Pharmaceuticals Inc – Company Statement
Syndax Pharmaceuticals Inc – Locations And Subsidiaries
Syndax Pharmaceuticals Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Syndax Pharmaceuticals Inc – Business Description
Syndax Pharmaceuticals Inc – Corporate Strategy
Syndax Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Syndax Pharmaceuticals Inc – Strengths
Syndax Pharmaceuticals Inc – Weaknesses
Syndax Pharmaceuticals Inc – Opportunities
Syndax Pharmaceuticals Inc – Threats
Syndax Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Syndax Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Syndax Pharmaceuticals Inc, Key Information
Syndax Pharmaceuticals Inc, Key Ratios
Syndax Pharmaceuticals Inc, Share Data
Syndax Pharmaceuticals Inc, Major Products and Services
Syndax Pharmaceuticals Inc, History
Syndax Pharmaceuticals Inc, Key Employees
Syndax Pharmaceuticals Inc, Key Employee Biographies
Syndax Pharmaceuticals Inc, Key Operational Heads
Syndax Pharmaceuticals Inc, Other Locations
Syndax Pharmaceuticals Inc, Subsidiaries
Syndax Pharmaceuticals Inc, Key Competitors
Syndax Pharmaceuticals Inc, SWOT Analysis
Syndax Pharmaceuticals Inc, Ratios based on current share price
Syndax Pharmaceuticals Inc, Annual Ratios
Syndax Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Syndax Pharmaceuticals Inc (SNDX):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • QPR Software Oyj (QPR1V):企業の財務・戦略的SWOT分析
    Summary QPR Software Oyj (QPR) is a technology company that provides software and solutions support. The company’s products include QPR business operating system, QPR process analyzer, QPR enterprise architect, QPR process designer, QPR metrics and QPR connectors. It offers solutions such as interna …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bayshore Petroleum Corp (BSH):企業の財務・戦略的SWOT分析
    Summary Bayshore Petroleum Corp (Bayshore Petroleum) is an oil and gas company that explores, produces, and develops natural gas and petroleum. The company develops conventional and unconventional oil and gas prospects in North America and across the world. It utilizes CCC technology for heavy oil a …
  • Antiva Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Antiva Biosciences Inc (Antiva) formerly Hera Therapeutics Inc, is a clinical stage bio-pharmaceutical company focused on the development of novel medicines for the treatment of diseases caused by human papillomavirus (HPV) infection. Its lead product candidate ABI-1968, is a double prodrug …
  • The Ensign Group Inc (ENSG):企業の財務・戦略的SWOT分析
    The Ensign Group Inc (ENSG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Carr’s Group Plc (CARR):企業の財務・戦略的SWOT分析
    Carr's Group Plc (CARR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Flint Hills Resources LLC:企業の戦略的SWOT分析
    Flint Hills Resources LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Computershare Limited (CPU):企業の財務・戦略的SWOT分析
    Computershare Limited (CPU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fluor Corp (FLR):企業の財務・戦略的SWOT分析
    Fluor Corp (FLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Quantum Fuel Systems LLC:企業の戦略的SWOT分析
    Quantum Fuel Systems LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Saras SpA (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras SpA (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industrial …
  • Ko Yo Chemical (Group) Ltd (827):企業の財務・戦略的SWOT分析
    Ko Yo Chemical (Group) Ltd (827) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Himatsingka Seide Ltd.:戦略・SWOT・企業財務分析
    Himatsingka Seide Ltd. - Strategy, SWOT and Corporate Finance Report Summary Himatsingka Seide Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • UroGen Pharma Ltd (URGN)-製薬・医療分野:企業M&A・提携分析
    Summary UroGen Pharma Ltd (UroGen Pharma), formerly TheraCoat Ltd is a biopharmaceutical company that develops uro-oncology drugs and urological pathologies. The company’s pipeline products comprise drug candidates for various forms of non-muscle invasive urothelial cancer, including low grade bladd …
  • Petroleos Mexicanos:石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleos Mexicanos (PEMEX) is a state-owned integrated oil and gas company. It operates across the value chain of oil and gas industry, from exploration and production to processing, logistics and marketing. PEMEX also produces and distributes a wide range of petrochemical products. The com …
  • Sir Robert McAlpine Ltd:企業の戦略的SWOT分析
    Sir Robert McAlpine Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • GMR Infrastructure Ltd (GMRINFRA):企業の財務・戦略的SWOT分析
    GMR Infrastructure Ltd (GMRINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Bilfinger SE (GBF):電力:M&Aディール及び事業提携情報
    Summary Bilfinger SE (Bilfinger) is a provider of industrial engineering services. It offers a wide range of services from consulting, construction, manufacturing, plant expansion to maintenance and project management services across diverse end markets. The company’s major service offerings include …
  • MannKind Corp (MNKD)-医療機器分野:企業M&A・提携分析
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that discovers, develops and commercializes therapeutic products to treat diseases such as diabetes. The company’s lead product, Afrezza is a rapid-acting, inhaled insulin used to control high blood sugar in adults with type 1 and type …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆